KRAS and colon adenocarcinoma: In COAD, PLXNA3 expression was negatively associated with key oncogenic and immunoregulatory pathways including Interferon Gamma Response, KRAS signaling, Oxidative Phosphorylation, Myc Targets V1, Inflammatory Response, and E2F Targets.